Treatment of cefazolin in 45 cases of urinary tract infections. 1977

R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur

We have treated 45 cases of urinary tract infection with cefazolin (i.m.) and cure was achieved in 35 (77.77%). 26 of the 28 patients (92.85%) with acute cystitis who received 250 mg every 12 h for 6-10 days were cured. 17 patients with pyelonephritis received 500 mg every 12 h during 10-14 days and therapeutical success was achieved in 9 of them (52.94%). Laboratory control was carried out at the initiation of therapy, at the end, and 1 month after therapy. Tolerance to injections of cefazolin was considered good and only in one case appeared a mild eosinophia.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011513 Proteus mirabilis A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.
D011704 Pyelonephritis Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA. Necrotizing Pyelonephritis,Pyelonephritis, Acute Necrotizing,Pyelonephritides
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002437 Cefazolin A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Cephazolin,Ancef,Cefamedin,Cefamezine,Cefazolin Sodium,Cephamezine,Cephazolin Sodium,Gramaxin,Kefzol,Sodium Cephazolin,Totacef,Cephazolin, Sodium,Sodium, Cefazolin,Sodium, Cephazolin
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D003556 Cystitis Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain. Cystitides
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
April 1974, La Clinica terapeutica,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
October 1973, The Journal of infectious diseases,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
December 1970, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
July 1975, Die Medizinische Welt,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
January 1976, Acta gastro-enterologica Belgica,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
April 1972, The Japanese journal of antibiotics,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
January 1981, Clinical therapeutics,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
May 1978, The Journal of infectious diseases,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
February 1990, Harefuah,
R G Lus, and M C Calvo, and L G Lopez, and R C Cancer, and A M Molina, and E D Sanchez, and A C Parilla, and L L Mur
August 2019, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Copied contents to your clipboard!